The authors regret that due to an error when preparing the panels, the incorrect data was presented in lane 1 of Panel B. The revised [Fig. 1](#f0005){ref-type="fig"} showing the corrected Panel B is given below.Fig. 1Analysis of palmitoylation in HEK.TPα and HEK.TPβ cells. Panels A and B, HEK.TPβ (lane 1), HEK.TPα (lane 2), HEK 293 (lane 3, negative control) and HEK.hIP (lane 4, positive control) cells were metabolically labelled for 2 h at 37 °C (Panel A). Panels C and D, HEK.TPβ (lane 1), HEK.TPβ^C347S^ (lane 2), HEK.TPβ^C373,377S^ cells (lane 3) and HEK.TPβ^C347,373,377S^ (lane 4) cells were metabolically labelled for 2 h at 37 °C (Panel C). Thereafter, the HA-tagged receptors were immunoprecipitated with anti-HA 101R and resolved by SDS-PAGE followed by electroblotting onto PVDF membrane. The blots (A and C) were soaked in Amplify prior to fluorography for 60--90 days at − 70 °C. Following fluorographic exposure, PVDF membranes, or parallel membranes, in A and C were screened by immunoblot analysis using anti-HA 3F10 peroxidase-conjugated antibody followed by chemiluminescent detection to obtain Panels B and D, respectively. The positions of the molecular weight markers (kDa) are indicated to the left and right of Panels A and D, respectively. Panel E, the level of palmitoylation in HEK.hIP, HEK.TPα, HEK.TPβ, HEKHA.TPβ^C347S^, HEK.TPβ^C373,377S^ and HEK.TPβ^C347,373,377S^ cells relative to basal levels, in HEK 293 cells, was determined by Phosphorimage analysis. Data is presented as mean fold increase in palmitoylation over basal levels ± S.E.M. and are expressed in arbitrary units. The data are representative of three independent experiments. The asterisks indicate that palmitoylation levels of TPα, TPβ^C347S^, TPβ^C373,377S^ and TPβ^C347,373,377S^ cells were significantly lower than that of TPβ where \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.005.

The authors would like to apologise for any inconvenience caused.
